BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20045097)

  • 1. One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.
    Yu W; Fang Q; Zhu W; Wang H; Tien P; Zhang L; Chen Z
    Vaccine; 2010 Feb; 28(9):2088-96. PubMed ID: 20045097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
    Lu B; Yu W; Huang X; Wang H; Liu L; Chen Z
    J Biomed Biotechnol; 2011; 2011():970424. PubMed ID: 21765641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an attenuated Tiantan vaccinia virus by deletion of the ribonucleotide reductase large subunit.
    Kan S; Jia P; Sun L; Hu N; Li C; Lu H; Tian M; Qi Y; Jin N; Li X
    Arch Virol; 2014 Sep; 159(9):2223-31. PubMed ID: 24677065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.
    Huang X; Lu B; Yu W; Fang Q; Liu L; Zhuang K; Shen T; Wang H; Tian P; Zhang L; Chen Z
    PLoS One; 2009; 4(1):e4180. PubMed ID: 19159014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice against the highly pathogenic VV
    Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice.
    Liu H; Yu W; Tang X; Wang H; Ouyang W; Zhou J; Chen Z
    J Med Virol; 2010 May; 82(5):727-34. PubMed ID: 20336714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
    J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
    Wyatt LS; Earl PL; Eller LA; Moss B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
    Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
    Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
    Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
    J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity.
    Shchelkunov SN; Yakubitskiy SN; Sergeev AA; Kabanov AS; Bauer TV; Bulychev LE; Pyankov SA
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32722032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
    Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
    PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
    Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.